Basic info
Industry
biotechnology research
Sectors
Biotechnology
Galectin modulators
Myelofibrosis
Health Diagnostics
Galectin-3 inhibitors
Health Care
Oncology
LOXL2
Fibrosis treatment
Liver fibrosis
Inflammation
IPF
Date founded
2011
Funding rounds raised
Total raised
$90M
from 21 investors over 21 rounds
G
Galecto, Inc. raised $64M on September 25, 2020
Investors: Maverick Ventures, Ysios Capital, Novo Holdings, OrbiMed Advisors, Sunstone Life Science Ventures, Seventure Partners, Soleus Capital Management, L.P. and Sphera Fund
G
Galecto, Inc. raised $90M on October 26, 2018
Investors: Maverick Ventures, Sunstone Life Science Ventures, M Ventures, Seventure Partners, Novo Holdings, Ysios Capital and Bristol-Myers Squibb, UK
G
Galecto, Inc. raised $6.3M on October 30, 2013
Investors: SEED Capital Denmark, Bay City Capital, Novo Holdings and M Ventures
G
Galecto, Inc. raised undisclosed on January 2, 2012
Investors: Novo Holdings and M Ventures